Harvard Bioscience, Inc.
USD6.17
+0.05 (+0.82%)
CEO
John D. Duke
IPO Date
2001-03-19
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Exchange
NASDAQ
Country
US
Open
$6.04
Prev. Close
$6.13
Day Low
$6.00
Day High
$6.17
52W Low
$3.80
52W High
$9.40
Market Cap
$0.03B
Volume
0.01M
| -7.4 |
| 31 Dec 2023 | FY | 58.9% | -3.0% | -4.7% | -2.5% | 0.59 | 1.85 | -66.5 |
| 31 Dec 2022 | FY | 53.7% | -8.4% | -13.2% | -6.5% | 0.75 | 2.20 | -12.1 |
| 31 Dec 2021 | FY | 56.9% | -0.2% | -0.3% | -0.2% | 0.68 | 2.43 | -987.6 |
| 31 Dec 2020 | FY | 56.8% | -7.6% | -10.2% | -5.0% | 0.75 | 2.46 | -21.2 |
| 31 Dec 2019 | FY | 55.4% | -4.0% | -5.7% | -2.8% | 0.79 | 2.12 | -24.6 |
| 31 Dec 2018 | FY | 52.3% | -2.9% | -4.2% | -2.1% | 0.74 | 2.54 | -32.9 |
| 31 Dec 2017 | FY | 46.7% | -0.8% | -1.1% | -0.8% | 0.15 | 3.39 | -128.2 |
| 31 Dec 2016 | FY | 46.3% | -4.1% | -6.0% | -4.0% | 0.19 | 3.11 | -24.2 |
| -2.6 |
| 30 Sept 2025 | Q3 | 58.4% | -6.0% | -8.8% | -1.6% | 3.04 | 0.81 | -4.0 |
| 30 Jun 2025 | Q2 | 50.7% | -11.2% | -14.5% | -2.8% | 2.75 | 0.81 | -2.2 |
| 31 Mar 2025 | Q1 | 56.0% | -231.2% | -339.3% | -63.1% | 3.01 | 0.81 | -0.1 |
| 31 Dec 2024 | Q4 | 57.1% | 0.1% | 0.0% | 0.0% | 0.70 | 0.82 | 1275.9 |
| 30 Sept 2024 | Q3 | 58.1% | -21.9% | -7.4% | -3.7% | 0.70 | 2.06 | -6.1 |
| 30 Jun 2024 | Q2 | 57.2% | -12.7% | -4.4% | -2.3% | 0.62 | 2.05 | -10.3 |
| 31 Mar 2024 | Q1 | 60.3% | -19.1% | -6.8% | -3.5% | 0.60 | 1.88 | -9.8 |
| 31 Dec 2023 | Q4 | 53.1% | -6.5% | -2.5% | -1.3% | 0.59 | 1.85 | -31.4 |